Search Results 11-20 of 17247 for peptide combinations
A Mayo Clinic study finds postmenopausal women using hormone therapy lost 35% more weight with tirzepatide, suggesting new obesity treatment strategies.
The purpose of this study is to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...
The primary objective of this study is to evaluate whether the combination of semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firsocostat ...
... combination with capecitabine in adult patients with gastrin releasing peptide receptor positive, estrogen receptor-positive, human epidermal growth ...
Ernst, M.D.. Cancer — solid tumor, Peptide vaccine, Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of ...
The proposed clinical trial will study the effects of 12 months of therapy with ARN-509 alone, or in combination with an LHRH agonist (LHRHa), each compared to ...
induced apoptosis should be employed. This study shows that the combination of either belinostat or vorinostat with paclitaxel may prove to be an effective ...
The purpose of this study is to evaluate patients who are intolerant of current enteral formula to be transitioned to peptide-based therapy to assess if ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.